A number of adverse cutaneous reactions may occur during therapy with an epidermal growth factor receptor (EGFR) inhibitor.
Cutaneous reactions that may occur:
(1) inflammatory response (burning or tenderness, erythema and/or edema)
(2) papulopustular rash (acneiform), especially over the face and upper trunk, which is followed by crusting
(3) periungual inflammation (paronychia)
(4) nail abnormalities, including brittleness
(5) alopecia with loss of hair and eyelashes
(6) dry skin (xerosis) with flaking
(7) pruritis
(8) telangiectasia
To read more or access our algorithms and calculators, please log in or register.
Purpose: To evaluate adverse cutaneous reactions to epidermal growth factor receptor (EGFR) inhibitor therapy.
Specialty: Hematology Oncology, Dermatology
Objective: adverse effects
ICD-10: T38.6,
